標題: Higher NAFLD fibrosis score is associated with impaired eGFR
作者: Hsieh, Meng-Hsuan
Wu, Kuan-Ta
Chen, Yi-Yu
Yang, Jeng-Fu
Lin, Wen-Yi
Chang, Ning-Chia
Lin, Chia-Yi
Huang, Chao-Kuan
Wang, Chao-Ling
Chuang, Hung-Yi
Lin, Shu-Ching
Hsu, Yu-Kuei
Tsai, Yi-Shan
Chuang, Wan-Long
Yu, Ming-Lung
Dai, Chia-Yen
生醫工程研究所
Institute of Biomedical Engineering
關鍵字: NAFLD fibrosis score;Estimated glomerular filtration rate;Fasting sugar;Waist circumference
公開日期: 1-一月-2020
摘要: Background/Purpose: Chronic kidney disease (CKD) has become a worldwide health problem, leading to high morbidity and mortality, and non-alcoholic fatty liver disease (NAFLD) is considered a risk factor for CKD. The aim of this study was to explore the relationship between NAFLD fibrosis score (NFS) and the estimated glomerular filtration rate (eGFR), and identify possible risk factors related to the NFS among Taiwanese subjects. Methods: Subjects were enrolled from the database of the Department of Preventive Medicine of Kaohsiung Municipal Hsiao-Kang Hospital. The eGFR was calculated according to the Taiwanese Modification of Diet in Renal Disease (TMDRD) equation, and the NFS was employed to evaluate the fibrotic level. Results: In total, 11,376 subjects were enrolled in this study, with a mean age of 52.0 +/- 6.81 years, including 4529 (39.8%) males. A fasting sugar level >= 100 mg/dL (OR = 1.70, 95% CI = 1.52-1.87) and an abnormal waist circumference (OR = 1.81, 95% CI = 1.65-1.99) were significant factors associated with NFS (p < 0.05). Trends of a decreasing TMDRD score and an increasing NFS with increasing age were noted (p < 0.05). The NFS was significantly negatively correlated with the TMDRD score (standard coefficients: -0.067, p < 0.001). Conclusion: A higher NFS is associated with an impaired eGFR in Taiwanese subjects. Controlling risk factors, especially fasting sugar level and waist circumference, may be useful in preventing NFS deterioration, which is negatively correlated with the eGFR. Copyright (C) 2019, Formosan Medical Association. Published by Elsevier Taiwan LLC.
URI: http://dx.doi.org/10.1016/j.jfma.2019.07.007
http://hdl.handle.net/11536/153644
ISSN: 0929-6646
DOI: 10.1016/j.jfma.2019.07.007
期刊: JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
Volume: 119
Issue: 1
起始頁: 496
結束頁: 503
顯示於類別:期刊論文